HYDERABAD, India - Soon-to-be brides and grooms seeking shortcuts ‌to shed pounds before the big ‌day have become the latest ...

Natco Pharma has launched the Semaglutide injection in India on the first day of its patent expiry. Hyderabad-based Natco received approval from Central Drugs Standard Control Organisation (CDSCO) to ...

Alkem Laboratories is all set to launch a semaglutide injection under the brand names Semasize, Obesema and Hepaglide priced ...

Indian pharma majors Sun Pharma, Dr Reddy's and Glenmark on Saturday announced the launch of their generic versions of ...

Zydus Lifesciences Limited (including its subsidiaries, hereafter referred to as "Zydus"), an innovation-led global lifesciences company, has launched Semaglutide Injection under the brand names - ...

Semaglutide is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to ...

Sun Pharmaceutical Industries has announced the launch of its semaglutide injection in India under the brand names Noveltreat and Sematrinity, across multiple strengths for the treatment of obesity ...

Zydus Lifesciences on Saturday announced the launch of Semaglutide Injection in India under the brand names SEMAGLYN™, MASHEMA™ and ALTERME™, following patent expiry.

Sun Pharma introduces semaglutide injection under the brand names, Noveltreat and Sematrinity in India: Our Bureau, Mumbai Saturday, March 21, 2026, 14:15 Hrs [IST] Sun Pharmaceut ...